Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

More articles from Article

  • You have access
    Structural Determinants of Kv7.5 Potassium Channels That Confer Changes in Phosphatidylinositol 4,5-Bisphosphate (PIP2) Affinity and Signaling Sensitivities in Smooth Muscle Cells
    Lyubov I. Brueggemann, Leanne L. Cribbs and Kenneth L. Byron
    Molecular Pharmacology March 2020, 97 (3) 145-158; DOI: https://doi.org/10.1124/mol.119.117192
  • Ser100-Phosphorylated ROR<em>α</em> Orchestrates CAR and HNF4<em>α</em> to Form Active Chromatin Complex in Response to Phenobarbital to Regulate Induction of CYP2B6
    You have access
    Ser100-Phosphorylated RORα Orchestrates CAR and HNF4α to Form Active Chromatin Complex in Response to Phenobarbital to Regulate Induction of CYP2B6
    Muluneh Fashe, Takuyu Hashiguchi, Masahiko Negishi and Tatsuya Sueyoshi
    Molecular Pharmacology March 2020, 97 (3) 191-201; DOI: https://doi.org/10.1124/mol.119.118273
  • You have access
    Interactions between Atorvastatin and the Farnesoid X Receptor Impair Insulinotropic Effects of Bile Acids and Modulate Diabetogenic Risk
    Theresa Hoffmeister, Julia Kaiser, Simon Lüdtke, Gisela Drews and Martina Düfer
    Molecular Pharmacology March 2020, 97 (3) 202-211; DOI: https://doi.org/10.1124/mol.119.118083
  • The Peroxisome Proliferator–Activated Receptor (PPAR)-<em>γ</em> Antagonist 2-Chloro-5-Nitro-N-Phenylbenzamide (GW9662) Triggers Perilipin 2 Expression via PPAR<em>δ</em> and Induces Lipogenesis and Triglyceride Accumulation in Human THP-1 Macrophages
    You have access
    The Peroxisome Proliferator–Activated Receptor (PPAR)-γ Antagonist 2-Chloro-5-Nitro-N-Phenylbenzamide (GW9662) Triggers Perilipin 2 Expression via PPARδ and Induces Lipogenesis and Triglyceride Accumulation in Human THP-1 Macrophages
    Martin Schubert, Stefanie Becher, Maria Wallert, Marten B. Maeß, Masoumeh Abhari, Knut Rennert, Alexander S. Mosig, Silke Große, Regine Heller, Michael Grün and Stefan Lorkowski
    Molecular Pharmacology March 2020, 97 (3) 212-225; DOI: https://doi.org/10.1124/mol.119.117887
  • You have access
    CITCO Directly Binds to and Activates Human Pregnane X Receptor
    Wenwei Lin, Monicah Bwayi, Jing Wu, Yongtao Li, Sergio C. Chai, Andrew D. Huber and Taosheng Chen
    Molecular Pharmacology March 2020, 97 (3) 180-190; DOI: https://doi.org/10.1124/mol.119.118513
  • You have access
    Anaplastic Lymphoma Kinase Regulates Internalization of the Dopamine D2 Receptor
    Donghong He and Amy W. Lasek
    Molecular Pharmacology February 2020, 97 (2) 123-131; DOI: https://doi.org/10.1124/mol.119.117473
  • You have access
    The IKs Ion Channel Activator Mefenamic Acid Requires KCNE1 and Modulates Channel Gating in a Subunit-Dependent Manner
    Yundi Wang, Jodene Eldstrom and David Fedida
    Molecular Pharmacology February 2020, 97 (2) 132-144; DOI: https://doi.org/10.1124/mol.119.117952
  • You have access
    Characterization and Optimization of the Novel Transient Receptor Potential Melastatin 2 Antagonist tatM2NX
    I. Cruz-Torres, D.S. Backos and P.S. Herson
    Molecular Pharmacology February 2020, 97 (2) 102-111; DOI: https://doi.org/10.1124/mol.119.117549
  • You have access
    Alternative Polyadenylation of ABC Transporters of the C-Family (ABCC1, ABCC2, ABCC3) and Implications on Posttranscriptional Micro-RNA Regulation
    Oliver Bruhn, Marie Lindsay, Friederike Wiebel, Meike Kaehler, Inga Nagel, Ruwen Böhm, Christian Röder and Ingolf Cascorbi
    Molecular Pharmacology February 2020, 97 (2) 112-122; DOI: https://doi.org/10.1124/mol.119.116590
  • You have access
    Evaluation of Operational Models of Agonism and Allosterism at Receptors with Multiple Orthosteric Binding Sites
    Karen J. Gregory, Jesús Giraldo, Jiayin Diao, Arthur Christopoulos and Katie Leach
    Molecular Pharmacology January 2020, 97 (1) 35-47; DOI: https://doi.org/10.1124/mol.119.118091

Pages

  • Previous
  • Next
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • …
  • 733
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics